Search Results 421-430 of 17011 for hla genotype

  1. Ph 3 Trial of Blinatumomab vs Investigator's Choice of Chemotherapy in Patients with Relapsed or Refractory ALL - Mayo Clinic

    This study seeks adult subjects with Relapsed/Refractory (R/R) B-precursor ALL. This is a phase 3 randomized, open label study designed to evaluate the efficacy ...

  2. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk factors and treatments, such as chemotherapy, radiation and bone marrow transplant.

  3. Fig. 1: E-cadherin loss and p120 overexpression in a case of clear renal cell carcinoma (cRCC). Normal tissue is shown in the top and tumor in the bottom ...

  4. Pulmonary Medicine - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  5. Chronic myelogenous leukemia - Doctors and departments - Mayo Clinic

    Learn about chronic myelogenous leukemia symptoms and causes. Find out how CML is treated, including targeted therapy and bone marrow transplant.

  6. Transforming Non-Invasive Liver Disease Detection by Magnetic Resonance Elastography - Mayo Clinic

    While invasive liver biopsy was required to detect cirrhosis, the development of magnetic resonance elastography (MRE) has revolutionized our ability to detect ...

  7. Collaborators - Genomic and Exposomic Hepatobiology: Konstantinos N. Lazaridis - Mayo Clinic Research

    Collaborators. Dr. Lazaridis is involved in several research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators.

  8. Hereditary Hemochromatosis Clinic in Florida - Overview

    Hereditary hemochromatosis is an inherited disease that makes your body absorb more iron than it needs, leading to iron overload. Over time, excess iron can ...

  9. Neurology - Clinical trials - Mayo Clinic

    Aims, purpose, or objectives: To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the ...

  10. To Evaluate The Long-term Safety And Tolerability Of Acoramidis In Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) - Mayo Clinic

    Key Inclusion Criteria: Participants must have completed the AG10-501 study (ACT-EARLY study) within the past 60 calendar days with a diagnosis of ATTR-CM ...